Can Cannabis Help Patients With Parkinson’s Infection?

Studies have suggested that cannabis might improve rest, tremor, and engine function.

VANCOUVER reports that are—Anecdotal client surveys, and research reports have recommended that cannabis might help treat motor and nonmotor the signs of Parkinson’s condition. Two studies presented during the twenty-first Overseas Congress of Parkinson’s infection and Movement Disorders further explored this possibility and evaluated the consequences of dental cannabidiol (CBD) and inhaled cannabis in clients with Parkinson’s condition.

Cannabidiol

Maureen A. Leehey, MD, Professor of Neurology and Chief associated with the Movement Disorders Division during the University of Colorado in Aurora, and peers conducted a phase II, open-label, dose-escalation study to judge the tolerability and safety of CBD (Epidiolex) in Parkinson’s condition. In addition, the researchers looked over additional efficacy measures, including improvement in tremor, cognition, anxiety, psychosis, rest, daytime sleepiness, mood, weakness, and discomfort.

Maureen A. Leehey, MD

The scientists enrolled 13 clients that has a rest tremor amplitude rating of 2 or greater on product 3.17 for the Parkinson’s that is unified Disease Scale (UPDRS). They excluded clients that has taken cannabinoids in the last thirty days or possessed reputation for medication or liquor dependence.

More than a treatment that is 31-day, patients received 5-, 7.5-, 10-, 15-, and 20-mg/kg/day doses of CBD. They received the greatest dose on times 17–31. Clients had clinic visits at testing, standard, and following the 31-day therapy period. Continue reading →